Literature DB >> 1650854

Tube feeding-related diarrhea in acutely Ill patients.

P A Guenter1, R G Settle, S Perlmutter, P L Marino, G A DeSimone, R H Rolandelli.   

Abstract

Acutely ill patients received tube feeding for an average of 15.8 days and, on average, 35% of those days were spent in the intensive care unit (ICU). Patients were prospectively assigned either a fiber-free formula (FFF-OSMOLITE HN, Ross; n = 50) or a fiber-supplemented (soy polysaccharide 14.4 g/L) formula (FSF = JEVITY, Ross; n = 50). Diarrhea was defined as three or more loose or watery stools per day and occurred in 30% of all patients. Diarrhea developed in 29 (41%) of the 71 patients who received antibiotics during, or within 2 weeks prior to, the feeding period, whereas only 1 (3%) of the 29 patients not receiving antibiotics developed diarrhea (p less than 0.005); and this patient developed diarrhea on the day of death. Among the 30 patients with diarrhea, stool Clostridium difficile (CD) toxin was positive in 15 (50%), negative in 11 (37%), and was not measured in four. The mean serum albumin was significantly lower in patients with diarrhea (2.43) than in those without diarrhea (2.75) (p = 0.043). There were no significant differences in age, sex, diagnoses, number of feeding days, and percent ICU days between patients with and without diarrhea. While not statistically significant, patients who received FSF were observed to have a lower incidence of diarrhea, a lower percentage of diarrhea days per total feeding days, and a lower frequency of positive CD toxin assays than patients who received FFF. In this patient population, antibiotic usage was the factor most strongly associated with diarrhea during tube feedings.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650854     DOI: 10.1177/0148607191015003277

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  15 in total

Review 1.  Enteral feeding. Nasogastric, nasojejunal, percutaneous endoscopic gastrostomy, or jejunostomy: its indications and limitations.

Authors:  C B Pearce; H D Duncan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

2.  Guidelines for enteral feeding in adult hospital patients.

Authors:  M Stroud; H Duncan; J Nightingale
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 3.  Enteral nutrition and the critically ill.

Authors:  S A Shikora; A M Ogawa
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

4.  Colonic responses to enteral tube feeding.

Authors:  T E Bowling; D B Silk
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

5.  Correction of malnutrition following gastrectomy with cyclic enteral nutrition.

Authors:  X Hébuterne; F Vaillon; J L Peroux; P Rampal
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

6.  Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.

Authors:  Stephane-M Schneider; Fernand Girard-Pipau; Jerome Filippi; Xavier Hebuterne; Dominique Moyse; Gustavo-Calle Hinojosa; Anne Pompei; Patrick Rampal
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 7.  Fiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysis.

Authors:  Mazuin Kamarul Zaman; Kin-Fah Chin; Vineya Rai; Hazreen Abdul Majid
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 8.  Fiber in the ICU: Should it Be a Regular Part of Feeding?

Authors:  Caitlin H Green; Rebecca A Busch; Jayshil J Patel
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

9.  Efficacy of half-solid nutrient for the elderly patients with percutaneous endoscopic gastrostomy.

Authors:  Toshitsugu Shizuku; Kyoichi Adachi; Kenji Furuta; Misa Niigaki; Yuko Miyaoka; Setsushi Katoh; Kyoko Kobayashi; Mitsuru Otani; Kohsaku Kawashima; Jun Otani; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2011-04-13       Impact factor: 3.114

10.  A randomized controlled pilot study to evaluate the effect of an enteral formulation designed to improve gastrointestinal tolerance in the critically ill patient-the SPIRIT trial.

Authors:  Stephan M Jakob; Lukas Bütikofer; David Berger; Michael Coslovsky; Jukka Takala
Journal:  Crit Care       Date:  2017-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.